May 04, 2026
Singapore, May 4: Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at the 106th American Association for Thoracic Surgery Annual Meeting.
Read More...
May 04, 2026
Kathmandu [Nepal], May 4: As global fuel markets reel from the Middle East war, motorists in Nepal...
May 04, 2026
Doha [Qatar], May 4: Qatar and Austria have signed a protocol amending certain provisions of the agreement...
May 04, 2026
Riyadh [Saudi Arabia], May 4: OPEC+ announced its decision to increase oil production by 188,000 barrels per...
May 03, 2026
May 03, 2026
May 02, 2026
